TP53 and hepatocellular carcinoma: Inactivation of p53 leads to aberrant mitosis, chromosome instability, more aggressive tumorigenesis, and poor prognosis in HCC [4], [35], whereas the β-catenin mutation is associated with low tumor grade and low tumor stage, and better patient survival [34].